Cargando…

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer

Bladder cancer is one of the most incident neoplasms worldwide, and its treatment remains a significant challenge, since the mechanisms underlying disease progression are still poorly understood. The epithelial to mesenchymal transition (EMT) has been proven to play an important role in the tumorige...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monteiro-Reis, Sara, Lobo, João, Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358899/ https://www.ncbi.nlm.nih.gov/pubmed/30642115 http://dx.doi.org/10.3390/ijms20020297

Ejemplares similares

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression
por: Lobo, João, et al.
Publicado: (2020)

Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
por: Martins-Lima, Cláudia, et al.
Publicado: (2023)

Targeting the Immune system and Epigenetic Landscape of Urological Tumors
por: Lobo, João, et al.
Publicado: (2020)

Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2020)

Epigenetic reprogramming in the epithelial-to-mesenchymal transition
por: Hoang, Stephen, et al.
Publicado: (2012)

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
por: Lobo, João, et al.
Publicado: (2019)

Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer
por: Roche, Joëlle, et al.
Publicado: (2017)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
por: Huang, Jun, et al.
Publicado: (2019)

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
por: Sciacovelli, Marco, et al.
Publicado: (2016)

Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer
por: Bedi, Upasana, et al.
Publicado: (2014)

LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer
por: Ma, Yan, et al.
Publicado: (2022)

Downregulation of m(6)A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness
por: Guimarães‐Teixeira, Catarina, et al.
Publicado: (2022)

Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007)

Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
por: Zhang, Juyong, et al.
Publicado: (2013)

Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition
por: McDonald, Oliver G., et al.
Publicado: (2011)

Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition
por: Cieślik, Marcin, et al.
Publicado: (2013)

Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes
por: Kao, Shih-Han, et al.
Publicado: (2016)

Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis
por: Chen, Hsiao-Fan, et al.
Publicado: (2016)

Epigenetic Regulation of Elf5 Is Associated with Epithelial-Mesenchymal Transition in Urothelial Cancer
por: Wu, Bo, et al.
Publicado: (2015)

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2020)

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2018)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
por: Lobo, João, et al.
Publicado: (2020)

Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
por: Liu, Qiu-Luo, et al.
Publicado: (2021)

The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors
por: Lobo, João, et al.
Publicado: (2018)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
por: Serrano-Gomez, Silvia Juliana, et al.
Publicado: (2016)

Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
por: Skibba, Melissa, et al.
Publicado: (2020)

An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: Makena, Monish Ram, et al.
Publicado: (2021)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2018)

Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
por: Lopes, Nair, et al.
Publicado: (2020)

A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
por: Viveiros, Nicole, et al.
Publicado: (2022)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hv6cjhnk2404ubq8u263gb0fmi